PCL/gelatin scaffolds and beta‐boswellic acid synergistically increase the efficiency of CGR8 stem cells differentiation into dopaminergic neuron: A new paradigm of Parkinson's disease cell therapy
Authors:
- 25 June 2020
- journal article
- research article
- Published by Wiley in Journal of Biomedical Materials Research Part A
- Vol. 109 (4) , 562-571
Abstract
Parkinson's disease is a progressive degenerative disorder in the central nervous system (CNS), which is distinguished by the death of dopamine producing nerve cells. Levodopa, a dopamine precursor drug, is the current standard of care of symptomatic treatment for Parkinson's disease. However, the long‐term use of the drug is associated with the development of motor fluctuations and dyskinesias. Cellular therapies aim to deploy fetal dopaminergic neurons as a means to replace the missing dopamine‐producing cells. The present study aims to study the impact of Beta‐Boswellic Acid (BBA) coupled with poly ε‐caprolactone (PCL)/gelatin scaffolds on the dopaminergic differentiation course of CGR8 embryonic stem cells (ESCs). For this purpose, CGR8 ESCs were cultured on PCL/gelatin scaffolds and a five‐step protocol was employed to be promoted the neural differentiation of CGR8 ESCs. Gene expression analysis by real ‐time qPCR demonstrated that PCL/gelatin scaffolds along with BBA treatment impose synergistic effects on the derivation of dopaminergic‐like cells from CGR8 ESCs. Reverse phase high‐performance liquid chromatography HPLC confirmed the functionality of the derived neurons by demonstrating the efficient secretion of dopamine in response to stimuli. Our results suggested that the generation of functional dopaminergic‐like cells from CGR8 ESCs was increased and supported by PCL/gelatin scaffolds and BBA treatment can heighten the efficiency. The result of this study may open insight into Parkinson's disease cell therapy and provide future directions for tissue engineering aimed at the treatment of Parkinson's disease.Keywords
Funding Information
- Tehran University of Medical Sciences and Health Services (34276‐87‐01‐80)
This publication has 24 references indexed in Scilit:
- The Development of a ɛ-Polycaprolactone Scaffold for Central Nervous System RepairTissue Engineering Part A, 2013
- Stem cell differentiation to epidermal lineages on electrospun nanofibrous substrates for skin tissue engineeringActa Biomaterialia, 2011
- Differentiation of human ES and Parkinson's disease iPS cells into ventral midbrain dopaminergic neurons requires a high activity form of SHH, FGF8a and specific regionalization by retinoic acidMolecular and Cellular Neuroscience, 2010
- Influence of Gelatin Cues in PCL Electrospun Membranes on Nerve OutgrowthBiomacromolecules, 2010
- The enhancement effect of beta-boswellic acid on hippocampal neurites outgrowth and branching (an in vitro study)Neurological Sciences, 2010
- Electrospun poly(ɛ-caprolactone)/gelatin nanofibrous scaffolds for nerve tissue engineeringBiomaterials, 2008
- Stages in the development of Parkinson’s disease-related pathologyCell and tissue research, 2004
- The DaNeX Study of Embryonic Mesencephalic, Dopaminergic Tissue Grafted to a Minipig Model of Parkinson's Disease: Preliminary Findings of Effect of MPTP Poisoning on Striatal Dopaminergic MarkersCell Transplantation, 2000
- Ontogeny of microtubule-associated protein 2 in rat cerebellum: Differential expression of the doublet polypeptidesNeuroscience, 1984
- Immunocytochemical localization of actin and microtubule-associated protein MAP2 in dendritic spines.Proceedings of the National Academy of Sciences, 1983